Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
about
Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells.Angiogenesis in urological malignancy: prognostic indicator and therapeutic target.Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsKinetics of Kaposi's sarcoma-associated herpesvirus gene expression.Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factorCytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.Angiogenic properties of human immunodeficiency virus type 1 Tat proteinAngiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaFibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.Effect of lead on ERK activity and the protective function of bFGF in rat primary culture astrogliaCurrent methods for assaying angiogenesis in vitro and in vivo.Antitumour effects of antiretroviral therapy.Recent insights into the pathogenesis of Kaposi's sarcomaA critical analysis of current in vitro and in vivo angiogenesis assays.Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells.Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor.Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells.Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3.Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells.Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts.Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.Endothelial cell malignancies: new insights from the laboratory and clinic.Emerging therapeutic targets in angiogenesis
P2860
Q32163310-961F2CAA-B642-4554-A118-CEF30310980FQ33598141-F78C3A1F-CAB1-4262-8A3D-F2E1120AF5B4Q33647345-0A9A5E8F-AF42-4BB9-8843-417DC1C54CE4Q33653424-D083B433-20EC-479B-BBAC-E6D51F5BD55FQ33948194-C765806F-EE87-4D94-8563-F8EEA739004BQ34209585-639E0502-D3E6-4E67-8B5C-1055E216B7F3Q34267637-99340CBC-48E7-4AC0-BCF3-7AA46A0F500BQ34587184-9385EC5D-1218-414E-AB19-9AD696A35768Q35080730-6E1A503F-9480-4B1A-82C9-EF8B1AF65C0AQ35294664-964B9C3F-7934-4F20-A356-AD3CBE57BB55Q35741522-7ECF67EA-2122-4DBB-8A4C-55648C32D935Q35745558-9A95DDE0-E34B-4D43-B474-E1EDB9E6C5F6Q35765203-0538AA25-C3EB-4594-9325-D9A8780B9DE3Q35773499-98EA734E-B42F-4B97-843D-69A0E63AAAA0Q35815140-84733613-94F7-47C9-8D9C-0C35C078E924Q35893291-D0915873-731F-4468-9C2A-8106641C76CAQ35934144-2D834463-B6D2-46BB-94A9-F01838BAD864Q36135122-8A6721EB-DE30-4978-83A1-5A3A44A51579Q37534963-26809E7B-DC5E-43EF-8D7C-664684AA347AQ38353450-4D2A088D-CD42-4F51-BB2F-3FD443711237Q38778545-5E0C367F-9CFE-4DB9-B69B-0ED7DC5D64C8Q39605725-BF25A9FB-034A-46DB-8978-3AD34B557E43Q40364647-1EF950C3-EC4E-469A-9A7A-608BEFAB705DQ40738783-79737BC3-EF31-49FC-848D-91E564F6DC04Q40779601-79E4684B-2A7D-483E-B440-75FBA67909F2Q40797022-07FC5291-71FE-4AB5-A1A0-86C7EC273918Q41974606-F87B9A8F-363E-4F72-BE07-44E08E763A32Q42710003-67332CFA-2CC4-47C1-9518-E4CCB0BFC9A3Q43971243-149DD593-AB45-4278-B311-E61750920505Q52519666-CCE8777E-3CAA-4B82-B880-507C5E259CD2Q53406374-B1D1ED47-0AFB-40BB-AE5E-AC0E2A625151Q53964090-3DC07C52-194F-47B6-9C5A-C6B283AB5722Q55332047-CBD46B72-4BDB-4A20-8B49-32F45C9564D1Q58212229-D8999E67-0CC8-4F51-944F-D2089689C827
P2860
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@ast
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@en
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@nl
type
label
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@ast
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@en
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@nl
prefLabel
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@ast
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@en
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@nl
P2093
P2860
P356
P1476
Block of AIDS-Kaposi's sarcoma ...... trategy for the therapy of KS.
@en
P2093
Barillari G
Fiorelli V
Gendelman R
P2860
P304
P356
10.1172/JCI117521
P407
P50
P577
1994-11-01T00:00:00Z